| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $54.0M | +67.9% |
| SG&A Expense | $17.6M | +59.9% |
| Operating Income | -$71.7M | -65.8% |
| Income Tax | $0 | — |
| Net Income | -$67.6M | -58.0% |
| EPS (Basic) | -$1.26 | -10.5% |
| EPS (Diluted) | -$1.26 | -10.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.0M | +41.3% |
| Current Assets | $357.0M | +25.8% |
| Total Assets | $367.1M | +28.7% |
| Current Liabilities | $16.6M | +57.6% |
| Total Liabilities | $20.4M | +87.9% |
| Stockholders' Equity | $346.7M | +26.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$52.6M | -57.1% |
| Capital Expenditures | $5.5M | +730.2% |
| Investing Cash Flow | -$70.6M | +70.9% |
| Financing Cash Flow | $129.6M | -30.4% |
| Free Cash Flow | -$58.2M | -70.2% |